
Sign up to save your podcasts
Or


Friday, November 13, 2026
In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Eva Johnson cover two large heart drug trials that lowered markers but not events. They break down Lp(a)HORIZON, which tested pelacarsen, and ZEUS, which tested ziltivekimab. They explain why moving a risk marker is not the same as changing outcomes. Plus: they also discuss an FDA investigation into tumors after the SMA gene therapy Zolgensma, what monitoring may mean for practice, an NFL star's scary neck injury, and more.
Coverage Timeline:
(00:00) This Week’s Headlines
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, November 6, 2026
In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover a new JAMA Network Open estimate that 74.5 percent of deceased former NFL players had CTE after correcting for brain bank selection bias. They break down how researchers modeled donation bias and why the finding still cannot estimate risk for living players. They also dig into how the NFL and players association responded and what it means for counseling patients on head injury risk. Plus: they also discuss the 2026 midterm election results in which several doctors won their races, CVS splitting up, a major dialysis trial that stopped early, and more.
Coverage Timeline:
(00:00) Intro
(01:27) CTE Among Former NFL Players
(05:30) French ICU Dialysis Trial
(09:09) 2026 Midterm Result
(13:05) CVS Health Split
(14:30) Phone Location Data
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, October 30, 2026
In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Eva Johnson cover full phase three results for a Lyme disease vaccine, and Psychiatry Boot Camp host Dr. Mark Mullen pays a visit. They break down a new once monthly olanzapine shot for schizophrenia. Plus: a dementia study built on a 1972 British school reform, why Christina Applegate says her MS diagnosis was wrong, and GLP-1 drugs may affect drinking habits in the UK.
Thank you to guest anchor Dr. Mark Mullen! Check out his podcast Psychiatry Boot Camp, available every other Monday on YouTube and all your favorite podcast apps. To learn more, visit psychiatrybootcamp.com
Coverage Timeline:
(0:00) Intro
(1:26) Lyme Disease Vaccine
(3:31) Vaccine Safety & History
(5:07) Schizophrenia Treatment
(8:26) School & Dementia
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, October 23, 2026
In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a phase three trial of nicotinamide riboside in early Parkinson disease. Over 52 weeks, the supplement boosted NAD metabolism but showed no clinical benefit, raising questions for NAD boosting strategies. They also walk through a large hospital comparison of phenobarbital and diazepam for alcohol withdrawal, with similar stays and ventilation rates and fewer self directed discharges on phenobarbital, and why diazepam protocols may stay the course pending randomized trials. Plus: they also discuss national measles trends, FDA warning letters to Amazon and Walmart, and more.
Coverage Timeline:
(00:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, October 16, 2026
In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover the FDA clearance of Motivista as the first prescription app for negative symptoms of schizophrenia. They break down the 16 week CONVOKE trial and what a 2.6 point edge over a control app means for stable patients on antipsychotics. They also review new ACP guidance placing menopausal hormone therapy first for hot flashes and night sweats, with second and third line options. Plus: they discuss early feasibility data on a medical AI chatbot for pre visit histories, new federal recommendations on concentrated kratom products, and more.
Coverage Timeline:
(00:00) Intro
(01:08) Schizophrenia App Cleared
(03:50) Hot Flashes Guidance
(04:47) Dogs & Sleep Study
(06:51) AI In Urgent Care
(08:37) Awards & Dahlias
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, October 9, 2026
In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover Phase 3 results for retatrutide with up to 28.3% average weight loss at 80 weeks. They explain dosing, tolerability and what remains unproven for heart and kidney outcomes and how retatrutide compares with current GLP-1 options. They also break down a federal proposal to modernize airline emergency kits around nine life threatening categories with airline level discretion. Plus: they discuss a growing pediatric heart valve, the return of Doc, Best Medicine, Chicago Med and Grey’s Anatomy, and more.
Coverage Timeline:
(00:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit https://www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At:
https://www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, October 2, 2026
In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) joins Medlines as a new anchor! She and Eva Johnson cover an FDA advisory panel vote on an early cancer detection blood test for adults 50 and older. The panel called the test safe, then split on whether it works. The agency still has to rule. They also walk through a UCSF comparison of myomectomy and radiofrequency ablation for uterine fibroids. Both treatments improved symptoms over two years, and neither difference reached the study threshold for a clinically important advantage. Plus: new findings on animal therapy, and more.
Coverage Timeline:
(00:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At:
www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, September 25, 2026
In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@Adjoro) cover new research on colonoscopy surveillance after high risk adenomas. A large randomized trial found that waiting five years instead of three led to nearly identical colorectal cancer rates. They explain what the interim results mean for screening guidance and what remains unanswered. Then they turn to a Washington court ruling on whether raw audio from an AI scribe counts as part of the medical record. Plus: they discuss Nathan Fielder’s documentary on Theranos founder Elizabeth Holmes, prenatal diet and food allergy risk, and more.
Coverage Timeline:
(0:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, September 18, 2026
In today's episode, Dr. Alok Patel (@AlokPatelMD) & Eva Johnson cover new migraine prevention guidelines that put CGRP targeted therapies up front as first line options without requiring older drugs first. They explain who qualifies at four or more headache days per month, how to assess response after 8 to 12 weeks, and safety notes for pregnancy. They also break down The Pitt's second Emmy run, with 25 nominations and back to back wins for Noah Wyle and Outstanding Drama. Plus: rising rabies exposures, an MRSA outbreak tied to bouncy castles, and more.
Coverage Timeline:
(00:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
Friday, September 11, 2026
In today's episode, Dr. Alok Patel (@AlokPatelMD) & Adam Rose (@Adjoro) cover a record pig kidney bridge that kept a New Hampshire man off dialysis for 271 days with no sign of rejection and without blocking his next human transplant. They break down the 69 edits behind the eGenesis organ and why The Lancet case matters for over 100,000 Americans waiting for a kidney. They also dig into new UK and US surveys showing most emergency staff face violence and what leaders say must change. Plus: a sharp rise in GLP-1 prescriptions for young children, fake weight loss drugs tied to liver injury, and more.
Coverage Timeline:
(00:00) Intro
Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email [email protected].
Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources
Medlines is a Human Content Production
From the publisher's feed
Ranked by our users in the last 21 days